Sterling Investment Advisors, Ltd.
Source: SEC Form 13F · as of Mar 2026Sterling Investment Advisors, Ltd. holds 16 biotech & pharma companies tracked by BioSniper, totaling $38.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$38.2M
| Company | Shares | Value |
|---|---|---|
| GMEDGlobus Medical Inc. | 144,023 | $12.4M |
| JNJJOHNSON & JOHNSON | 26,524 | $6.5M |
| AMGNAMGEN INC | 12,909 | $4.5M |
| CAHCardinal Health Inc. | 16,715 | $3.5M |
| PFEPFIZER INC | 124,752 | $3.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,122 | $2.4M |
| LLYELI LILLY & Co | 2,225 | $2.0M |
| ABTABBOTT LABORATORIES | 11,550 | $1.2M |
| IDXXIDEXX LABORATORIES INC /DE | 1,100 | $618K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,513 | $409K |
| PMPhilip Morris International Inc | 1,650 | $273K |
| GILDGILEAD SCIENCES, INC. | 1,657 | $231K |
| IMNMImmunome Inc. | 9,918 | $217K |
| ZTSZoetis Inc. | 1,800 | $213K |
| ANVSAnnovis Bio, Inc. | 23,416 | $52K |
| PRMEPrime Medicine, Inc. | 13,400 | $47K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.